ThinkProgress examines the commercial response to the ebola outbreak, and finds not just profiteering, but rank pseudoscience:
While a government-approved Ebola vaccine hasn’t been released as of yet, some pharmaceutical companies say that approved drugs could enter the market in the beginning of 2015. However, that hasn’t stopped companies from selling products they claim will cure or treat the disease.
In August, the Food and Drug Administration (FDA) issued warnings to three companies selling Ebola medications after consumers complained about the misleading claims that the manufacturers made, some of which included assertions like “viruses, including Ebola, are no match for our products” and “the Ebola virus cannot live in the presence of cinnamon bark.”
“This is an area where there’s little regulatory oversight unless the manufacturers suggest — which they don’t — that their merchandise has been reviewed by the government,” Dr. William A. Carter, Chairman & CEO of Hemispherx Biopharma, told ThinkProgress. Carter said that these companies have profited because Americans often let fear take precedence over logic, especially in cases of the unknown.